INDOAMIN NSI Week ended 07 Aug 2026

Weekly Investor Report

Indo Amines Limited · Basic Materials · Chemicals

Latest close 130.7 INR
2.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 10.7% above the Trend Line and sits at 57.2% of its 52-week range. The latest completed week returned 2.5%, after a 2.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 45 out of 100
Latest Close 130.7 INR 7 Aug 2026
1W Return 2.5% latest completed week
4W Return 2.7% short-term follow-through
12W Return 2.5% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 40.44% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.7% above the Trend Line and sits at 57.2% of its 52-week range. The latest completed week returned 2.5%, after a 2.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6612-week average 0.56

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.7% over four weeks, 2.5% over 12 weeks, and -5.1% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W2.5%
4W2.7%
12W2.5%
26W9.3%
52W-5.1%
Active trend streak8 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.09Latest activity-pressure read.
Pressure change-91.5%Four-week change in activity pressure.
Leadership5.42Latest relative-leadership reading.
RS change80.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength89/100Blend of value, momentum, and quality. Underlying universe rank 12; rank 1 is best.
Value88/100Relative valuation strength. Underlying universe rank 13; rank 1 is best.
Quality77/100Profitability and accounting quality. Underlying universe rank 24; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth68/100Revenue and earnings growth. Underlying universe rank 33; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework80/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.0x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
8.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
33.7%
Gross profit retained from each unit of revenue.
Operating margin
8.7%
Operating profit retained from revenue.
Free-cash-flow margin
0.0%
Free cash flow generated from revenue.
Return on invested capital
10.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.5%
Latest one-year revenue growth.
EPS growth
41.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 13 relevant articles.

1 positive · 12 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.9%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+10.3%Week of 10 Apr.
Worst week-7.8%Week of 20 Mar.
Latest week+2.5%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses7
Sharp losses7
Recent vol4.5%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026130.7 INR2.5%118.1 INR138.0 INR0.095.42379.3KOn
31 Jul 2026127.5 INR-1.5%117.9 INR137.9 INR0.233.46120.4KOn
24 Jul 2026129.5 INR5.3%118.0 INR137.8 INR0.457.46298.0KOn
17 Jul 2026122.9 INR-3.5%118.0 INR137.7 INR0.68-0.59175.3KOn
10 Jul 2026127.3 INR-2.7%118.1 INR137.6 INR1.023.00235.3KOn
3 Jul 2026130.8 INR-5.2%117.8 INR137.5 INR1.115.1346.5KOn
26 Jun 2026137.9 INR-3.9%117.4 INR137.4 INR1.1511.390On
19 Jun 2026143.6 INR9.7%116.9 INR137.3 INR1.2815.881.0MOn
12 Jun 2026130.9 INR-0.4%116.3 INR137.1 INR1.237.4663.4KOff
5 Jun 2026131.4 INR-1.8%116.4 INR137.0 INR1.388.79173.7KOff
29 May 2026133.7 INR7.2%116.4 INR136.9 INR1.529.682.0MOff
22 May 2026124.7 INR-2.2%116.4 INR136.9 INR1.301.50774.5KOff
15 May 2026127.5 INR3.6%116.7 INR136.7 INR1.153.963.2MOff
8 May 2026123.0 INR9.0%116.9 INR136.6 INR0.95-1.95744.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context